分子量: 2426.617 Da / 分子数: 2 / 由来タイプ: 合成 詳細: TWO MOLECULES OF THE DRUG UCH9 (DDA-DXA-DDA-DDL-DRI-DDA) BOUND IN THE MINOR GROOVE THE MODEL CONTAINS TWO MOLECULES OF UCH9 AND ONE MG CATION WHICH IS COORDINATED TO TWO UCH9 MOLECULES. IN ...詳細: TWO MOLECULES OF THE DRUG UCH9 (DDA-DXA-DDA-DDL-DRI-DDA) BOUND IN THE MINOR GROOVE THE MODEL CONTAINS TWO MOLECULES OF UCH9 AND ONE MG CATION WHICH IS COORDINATED TO TWO UCH9 MOLECULES. IN THIS ENTRY UCH9 IS PRESENTED AS HET GROUP, DDA-DXA-DDA-DDL-DRI-DDA. THESE GROUPS ARE NUMBERED 1-6 FOR ONE UCH9 AND 7-12 FOR THE OTHER UCH9.
タイプ: oligosaccharide / 分子量: 552.609 Da / 分子数: 2 / 由来タイプ: 合成 詳細: UCH9 WAS ISOLATED FROM STREPTOMYCES SP. THE DETAILS ARE SHOWN IN THE FOLLOWING PAPER: J. ANTIBIOTICS 51, 261-266,
タイプ: D-saccharide, beta linking / 分子量: 148.157 Da / 分子数: 2 / 由来タイプ: 合成 / 式: C6H12O4 詳細: UCH9 WAS ISOLATED FROM STREPTOMYCES SP. THE DETAILS ARE SHOWN IN THE FOLLOWING PAPER: J. ANTIBIOTICS 51, 261-266,
タイプ: Bruker DMX500 / 製造業者: Bruker / モデル: DMX500 / 磁場強度: 500 MHz
-
解析
NMR software
名称
バージョン
開発者
分類
X-PLOR
3.1
BRUNGER
精密化
X-PLOR
構造決定
精密化
手法: simulated annealing / ソフトェア番号: 1 詳細: REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. THE ABSOLUTE CONFIGURATION OF THE HYDROPHILIC SIDECHAIN HAS NOT BEEN DETERMINED. IN THIS MODEL, IT WAS SET TO THE SAME ...詳細: REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. THE ABSOLUTE CONFIGURATION OF THE HYDROPHILIC SIDECHAIN HAS NOT BEEN DETERMINED. IN THIS MODEL, IT WAS SET TO THE SAME CONFIGURATION AS THAT OF THE OTHER AUREOLIC ACID GROUP COMPOUNDS, SUCH AS CHROMOMYCIN A3.
NMRアンサンブル
コンフォーマー選択の基準: LEAST RESTRAINT VIOLATION 登録したコンフォーマーの数: 1